In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Practice Guideline Track on Valvular Heart Disease 2012

Guidelines into Practice

CV Surgery - Valves
Valvular Heart Disease
Non-coronary Cardiac Intervention

Contributors:  Special thanks to Bernard Prendergast and Bernard Iung from ESC Working Group on Valvular Heart Disease<

Based on the 2012 ESC Guidelines on the Management of Valvular Heart Disease.

Webinars on this topic

  2013 ESC webinar on "Challenges in asymptomatic mitral and aortic valve disease: the clinician's and the surgeon's perspective "  Watch the recording


Part 1 - Overview of the ESC/EACTS 2012 Guidelines on Valvular Heart disease

Presentation Slides Webcast
2012 ESC Guidelines overview: Valvular Heart Disease    
Evaluation before intervention    
Management of aortic stenosis    
Management of aortic regurgitation    
Management of mitral regurgitation    
Choice of prosthesis    
Meet with the task force    
State of the Art – Challenges in Valvular Heart Disease     


Part 2 - Topics in focus

Topic Presentation Slides Webcast
Aortic Valve Disease Pathology of calcific aortic valve disease  



Pathophysiology & prognosis of organic and functional mitral regurgitation  


Which treatment for which patient? Surgical valve repair vs. Medical therapy or ranscatheter intervention    
How to assess ischaemic mitral regurgitation    
Ischaemic mitral regurgitation: When is it too late for surgery?    
Valvular Disease
Clinical outcome of tricuspid regurgitation    
Assessing the impact of tricuspid regurgitation on the right ventricle    
Tricuspid valve surgery: when and how?     
Asymptomatic patients with aortic, mitral and tricuspid valve disease    
Aortic stenosis and mitral regurgitation in a high risk patient     
What do the guidelines say?     
Imaging What is new in the evaluation of aortic stenosis?    
Mitral regurgitation: quantify severity or assess consequences?      
Aortic regurgitation: when is quantification still a challenge?      
Mitral valve repair versus medical therapy or transcatheter intervention     
Mitral valve repair: intra-operative echocardiographic monitoring    
Patient-prosthesis mismatch     
Case Scenario: Meet the experts 
Percutaneous valve implantation or operation in aortic stenosis 
Severe aortic stenosis and intermediate operative risk     
Case scenario: severe aortic stenosis and mitral valve disease     
What do the guidelines say?    
Percutaneous Valve Interventions TAVI: What did we learn from clinical trials?    
TAVI and pre-procedural risk assessment     
TAVI: low-risk and high-risk patients.  What are the limits?      
TAVI: what do the guidelines tell us?      
How do we apply TAVI in the real world?     
Mitraclip in organic mitral regurgitation     
Mitraclip in functional mitral regurgitation     
Mitraclip: summary of current indications    
Valvular Heart Disease in pregnancy Severe aortic stenosis in pregnancy    
Pregnancy in a patient with a prosthetic valve     


Clinical cases on this topic